Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) antibody
Quick Overview for Recombinant ErbB2/Her2 (Trastuzumab Biosimilar) antibody (ABIN7542935)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Purpose
 - Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)], Mouse IgG2a, kappa
 - 
                                            
Specificity
 - Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30 % of invasive breast cancers and 70 % of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.
 - 
                                            
Characteristics
 - 
                        
Original Species of Ab: Human
Original Format of Ab: IgG1
 - 
                                            
Purification
 - Protein A affinity purified
 - 
                                            
Immunogen
 - A431 cells (human epidermoid carcinoma) (over)expressing EGFR.
 - 
                                            
Isotype
 - IgG2a kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - This antibody binds to erbB-2/Her-2/neu has therapeutic indications particularly in the treatment of breast cancer (c.f. Herceptin). It can also be used to detect HER-2 by flow cytometry or IHC (Glazyrin 2007).
 - 
                                            
Comment
 - 
                        
This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Concentration
 - 1 mg/mL
 - 
                                            
Buffer
 - PBS with 0.02 % Proclin 300.
 - 
                                            
Preservative
 - ProClin
 - 
                                            
Precaution of Use
 - This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
 
 - 
                                            
 - 
    
- ErbB2/Her2 (Trastuzumab Biosimilar)
 - 
                                            
Target Type
 - Biosimilar
 - 
                                            
Background
 - CD340, Metastatic lymph node gene 19 protein (MLN 19), Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine kinase-type cell surface receptor HER2, p185erbB2, p185HER2, EGFR
 - 
                                            
UniProt
 - P04626
 
Target
 -